x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




First Circuit upholds class certification in Nexium anti-competition case

26-01-2015

The US Court of Appeals for the First Circuit has upheld class certification in the Nexium (esomeprazole magnesium) pay-for-delay case.


Nexium, antitrust, class certification, AstraZeneca, US Court of Appeals for the First Circuit

WIPR

Payment types accepted